Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous adipose-derived mesenchymal stem cells (1 trial)
nkg2dl-targetting chimeric antigen receptor-grafted gamma delta t cell (2 trials)
Nasopharyngeal Carcinoma (Phase 1)
Triple Negative Breast Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (2 total)